Research
Intravenous phage therapy for difficult-to-treat infections: a systematic review and meta-analysis of individual patient data
Nature · By Fernando Arnaiz Guerrero ·
The Brief
- A systematic review and meta-analysis pools individual patient data on intravenous phage therapy for difficult-to-treat infections.
- It synthesises clinical, microbiological and safety outcomes.
- It also covers pharmacokinetic and immune neutralisation data.
Why it matters
It consolidates patient-level evidence on intravenous phage therapy, which clinicians and researchers can use to judge its clinical, microbiological and safety profile for hard-to-treat infections.
Who’s affected
- clinicians treating difficult-to-treat infections
- researchers working on phage therapy
- #phage therapy
- #meta-analysis
- #infectious disease
- #pharmacokinetics
- #immune neutralisation
Nature Communications, Published online: 20 November 2026; doi:10.1038/s41467-026-79491-9 This systematic review synthesises evidence on clinical, microbiological and safety outcomes of intravenous phage therapy, together with pharmacokinetic and immune neutralisation data…